Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
This is how artificial intelligence became part of everyday life
Artificial intelligence (AI) has become an almost invisible part of…
Read more >Many Hungarians flee to malls to escape the heat – research
Hungarian consumers consider air conditioning and light clothing to be…
Read more >Baggy eyes and bare trees – these are this year’s emoji trends
A heart, a laughing face or a spark – sometimes…
Read more >Related news
Beauty Expo presentations are also available online
The 4th Rossmann x Krémmánia Beauty Expo, held on May…
Read more >Tears in the Water benefit concert in September, charity campaign continues
Due to the extreme heat, the organizers postponed the “Tears…
Read more >Producers and consumers must be brought closer together
By strengthening the short supply chain, producers and consumers must…
Read more >